Michael P DiGiovanna MD, PhD

Associate Professor of Medicine (Medical Oncology) and of Pharmacology

Departments & Organizations

Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Cancer Center, Yale: Breast Cancer Program | Signal Transduction

Pharmacology

Medical Oncology

Signal Transduction

Research Interests

Breast cancer; HER-2/neu/ErbB-2; IGF1 receptor; EGF receptor; Growth factor receptor tyrosine protein kinases in malignancy; estrogen receptor, signal transduction

Clinical Interests

Breast Cancer

See Full Profile

Education

M.D., Yale University , 1990
Ph.D., Yale University , 1990

Selected Publication

Koay, D.C, Zerillo, C., Narayan, M., Harris, L.N. and DiGiovanna, M.P., “Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations”, Breast Cancer Research, 12:R62 [Epub ahead of print], 2010

Articles

Fall 2000 | Winter 2001

Yale’s M.D./Ph.D. Program celebrates a birthday and 188 promising careers

When Donald E. Ingber graduated from Yale College in 1977, he had definite ideas about what he wanted to do in life. He...